PHASE-III TRIAL; COOPERATIVE-ONCOLOGY-GROUP; PLUS GEMCITABINE; INHIBITION; HESPERIDIN; QUERCETIN; VEGF; ADENOCARCINOMA; COMBINATION; ACTIVATION
ONCOLOGY REPORTS, v.35, no.4, pp.2473 - 2479
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.